ArticleObstetric medicine2025
The impact of COVID-19 on the management of hypertensive disorders of pregnancy: An assessment of quality of care and outcomes.
Article in Obstetric medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypertensive disorders of pregnancy (HDP) affect up to 10% of women and require close monitoring to prevent adverse outcomes. The COVID-19 pandemic disrupted in-person care, prompting adaptations in follow-up strategies. This study assesses the pandemic's impact on HDP management at a Quebec tertiary-level health center. Methods: A retrospective cohort study compared a pandemic group to a prepandemic matched control group of pregnant women with HDP (2015-2020). The primary outcome was the difference in the total number of antenatal follow ups. Results: Although nonsignificant, total follow ups increased by 11% during the pandemic (RR = 1.11; p = 0.122), driven by a fivefold rise in telephone visits (RR = 5.05; p < 0.001), while in-person visits remained stable. Adverse outcomes rates showed no significant changes. Conclusion: Increased telehealth use complemented stable in-person care, supporting continuity and flexibility in HDP management. Telehealth holds promise as a supportive tool in prenatal care delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.